Edvard Smith is part of the 2017 2nd Semester, and 2021 2nd Semester cohorts at STIAS.
Projects
-
Systematic generation of an update of the ongoing studies on the new BTK inhibitors
BTK is a cytoplasmic protein-tyrosine kinase, whose corresponding gene was isolated in the early 1990s. BTK was initially identified by positional cloning ... -
Review on the use of BTK inhibitors
The beauty of BTK inhibitors is that they impair tumor development by blocking normal, unmutated BTK, causing many lymphoid tumors to be sensitive, as we h...
Related to Edvard Smith
Article
The complex interaction of virus and body - Fellows' seminar by Edvard Smith
The immune response to the SARS-CoV-2 virus and mechanisms underlying severe COVID-19 “The main way for the immune system to identify viruses is through a ...
Publication
Therapeutic Oligonucleotides: State of the Art
Smith, C.I. Edvard and Rula Zain. 2019. Therapeutic Oligonucleotides: State of the Art. Annual Review of Pharmacology and Toxicology, 59(1), 605–630. https...
Publication
Estimating the number of diseases – the concept of rare, ultra-rare, and hyper-rare
Smith, C. I. Edvard, Peter Bergman and Daniel W. Hagey. 2022. Estimating the number of diseases – the concept of rare, ultra-rare, and hyper-rare. iScience...